The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
High-Throughput FRET Assay Yields Allosteric SERCA Activators
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SERCA and PLN are key proteins within this tightly regulated process (3) and have been identified as potential drug targets (34, 35).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457
Self-citationGustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.015 · Cited by 63
Self-citation
Research works printed but not linked: 31
- Cantilina, 1993, Comparative Studies of Cardiac and Skeletal Sarcoplasmic Reticulum ATPases: Effect of a Phospholamban Antibody on Enzyme Activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- Karim, 2000, Synthetic Null-Cysteine Phospholamban Analogue and the Corresponding Transmembrane Domain Inhibit the Ca-ATPase, Biochemistry, 39, 10.1021/bi0003543 · DOI · Paper page
- Simmerman, 1986, Sequence Analysis of Phospholamban: Identification of Phosphorylation Sites and Two Major Structural Domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · DOI · Paper page
- Kranias, 2007, Calcium and Cardiomyopathies, Subcell Biochem., 45, 523, 10.1007/978-1-4020-6191-2_20 · DOI · Paper page
- Hadri, 2011, Calcium Cycling Proteins and Their Association with Heart Failure, Clin. Pharmacol. Ther., 90, 620, 10.1038/clpt.2011.161 · DOI
- Jessup, 2011, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients with Advanced Heart Failure, Circulation., 124, 304, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
- Johnson, 1998, Pharmacology of the Cardiac Sarcoplasmic Reticulum Calcium ATPase-Phospholamban Interaction, Ann. N. Y. Acad. Sci., 853, 380, 10.1111/j.1749-6632.1998.tb08305.x · DOI
- Mueller, 2004, Direct Detection of Phospholamban and Sarcoplasmic Reticulum Ca-ATPase Interaction in Membranes Using Fluorescence Resonance Energy Transfer, Biochemistry, 43, 8754, 10.1021/bi049732k · DOI
- Chen, 2007, Mechanism of Reversal of Phospholamban Inhibition of the Cardiac Ca2+-ATPase by Protein Kinase A and by Anti-phospholamban Monoclonal Antibody 2D12, J. Biol. Chem., 282, 20968, 10.1074/jbc.M703516200 · DOI
- Karim, 2006, Phosphorylation-Dependent Conformational Switch in Spin-Labeled Phospholamban Bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
- Gruber, 2012, Phospholamban Mutants Compete with Wild Type for SERCA Binding in Living Cells, Biochem. Biophys. Res. Commun., 420, 236, 10.1016/j.bbrc.2012.02.125 · DOI
- Fruen, 2000, Differential Ca(2+) Sensitivity of Skeletal and Cardiac Muscle Ryanodine Receptors in the Presence of Calmodulin, Am. J. Physiol. Cell Physiol., 279, C724, 10.1152/ajpcell.2000.279.3.C724 · doi:10.1152/ajpcell.2000.279.3.c724
- Ferrington, 1998, Comparison of the Stoichiomtery of Phospholamban to SERCA2a in Cardiac and Skeletal Muscle, Biophys. J., 74, 356
- Muretta, 2010, High-Performance Time-Resolved Fluorescence by Direct Waveform Recording, Rev. Sci. Instrum., 81, 103101-1, 10.1063/1.3480647 · doi:10.1063/1.3480647
- Lockamy, 2011, Functional and Physical Competition between Phospholamban and Its Mutants Provides Insight into the Molecular Mechanism of Gene Therapy for Heart Failure, Biochem. Biophys. Res. Commun., 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
- Chemaly, 2011, Long-term In Vivo Resistin Overexpression Induces Myocardial Dysfunction and Remodeling in rats, J. Mol. Cell Cardiol., 51, 144, 10.1016/j.yjmcc.2011.04.006 · DOI
- Jin, 2010, Mechanoelectrical Remodeling and Arrhythmias during Progression of Hypertrophy, Faseb J., 24, 451, 10.1096/fj.09-136622 · doi:10.1096/fj.09-136622
- Zhu, 2005, Increased Leakage of Sarcoplasmic Reticulum Ca2+ Contributes to Abnormal Myocyte Ca2+ Handling and Shortening in Sepsis, Crit. Care Med., 33, 598, 10.1097/01.CCM.0000152223.27176.A6 · doi:10.1097/01.ccm.0000152223.27176.a6
- Comley, 2010, Fluorescence Lifetime Finally Picking up Momentum!, Drug Discovery World, 71
- Li, 2012, Structural and Functional Dynamics of an Integral Membrane Protein Complex Modulated by Lipid Headgroup Charge, J. Mol. Biol., 418, 379, 10.1016/j.jmb.2012.02.011 · DOI · Paper page
- Espinoza-Fonseca, 2011, Atomic-Level Characterization of the Activation Mechanism of SERCA by Calcium, PLoS One., 6, e26936, 10.1371/journal.pone.0026936 · DOI · Paper page
- Schmidt, 1999, Human Heart Failure: cAMP Stimulation of SR Ca(2+)-ATPase Activity and Phosphorylation Level of Phospholamban, Am. J. Physiol., 277, H474
- Kawase, 2011, Rescuing the Failing Heart by Targeted Gene Transfer, J. Am. Coll. Cardiol., 57, 1169, 10.1016/j.jacc.2010.11.023 · DOI
- Kawase, 2008, Reversal of Cardiac Dysfunction after Long-term Expression of SERCA2a by Gene Transfer in a Pre-clinical Model of Heart Failure, J. Am. Coll. Cardiol., 51, 1112, 10.1016/j.jacc.2007.12.014 · DOI · Paper page
- Mayer, 2000, Characterization and Quantitation of Phospholamban and Its Phosphorylation State Using Antibodies, Biochem. Biophys. Res. Commun., 267, 40, 10.1006/bbrc.1999.1920 · doi:10.1006/bbrc.1999.1920
- Khan, 2009, Istaroxime, a First in Class New Chemical Entity Exhibiting SERCA-2 Activation and Na-K-ATPase Inhibition: A New Promising Treatment for Acute Heart Failure Syndromes?, Heart Fail. Rev., 14, 277, 10.1007/s10741-009-9136-z · DOI
- Gobbini, 2008, Novel Analogues of Istaroxime, a Potent Inhibitor of Na+,K+-ATPase: Synthesis and Structure-Activity Relationship, J. Med. Chem., 51, 4601, 10.1021/jm800257s · DOI
- Arbabian, 2011, Endoplasmic Reticulum Calcium Pumps and Cancer, Biofactors, 37, 139, 10.1002/biof.142 · DOI
- Fu, 2011, Aberrant Lipid Metabolism Disrupts Calcium Homeostasis Causing Liver Endoplasmic Reticulum Stress in Obesity, Nature, 473, 528, 10.1038/nature09968 · DOI · Paper page
- Goonasekera, 2011, Mitigation of Muscular Dystrophy in Mice by SERCA Overexpression in Skeletal Muscle, J. Clin. Invest., 121, 1044, 10.1172/JCI43844 · DOI · Paper page
- Gehrig, 2012, Hsp72 Preserves Muscle Function and Slows Progression of Severe Muscular Dystrophy, Nature, 484, 394, 10.1038/nature10980 · DOI · Paper page
Cited by
Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes
Arruda, A. P., & Hotamisligil, G. S. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.010 · Cited by 341
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738807 · Cited by 20
Vostrikov, V. V., Gustavsson, M., Gopinath, T., Mullen, D., Dicke, A. A., Truong, V., & Veglia, G. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00953 · Cited by 8
Development of a sensitive assay for SERCA activity using FRET detection of ADP
Jing, M., Verardi, R., Veglia, G., & Bowser, M. T. (2014) · Anal. Methods · doi:10.1039/c3ay41808a · Cited by 3
Metadata
- Authors
- Cornea, R. L., Gruber, S. J., Lockamy, E. L., Muretta, J. M., Jin, D., Chen, J., Dahl, R., Bartfai, T., Zsebo, K. M., Gillispie, G. D., & Thomas, D. D.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 18
- Issue
- 1
- Pages
- 97-107
- ISSN
- 2472-5552
- Cited by
- 97
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 3387 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.